Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Clinical-trials-phase-ii crawled date : 2022 - 11 - 03 save search
Syros Pharmaceuticals to Present Initial Data from SELECT-AML-1 Phase 2 Trial at 64th ASH Annual Meeting
Published: 2022-11-03 (Crawled : 15:00) - biospace.com/
SYRS | $4.99 9.91% 9.02% 150K
|
Health Technology
|
| O: -0.47%
H: 3.07%
C: -0.71%
pharmaceuticals meeting trial phase 2 aml
Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis at ASN’s Kidney Week 2022 Annual Meeting
Published: 2022-11-03 (Crawled : 15:00) - biospace.com/
KZR | $0.8222 4.08% 3.92% 710K
|
Health Technology
|
| O: -1.63%
H: 3.45%
C: -1.52%
sciences meeting lupus life kidney week trial positive results
REGENXBIO Presents Positive Interim Data from and the Expansion of Phase II ALTITUDE® Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery
Published: 2022-11-03 (Crawled : 12:00) - biospace.com/
RGNX | $15.68 -0.06% -0.06% 440K
|
Health Technology
|
| O: -3.01%
H: 0.77%
C: -10.46%
CLSD | News P | $1.41 7.63% 7.09% 300K
|
Health Technology
|
| O: 0.74%
H: 11.76%
C: 7.35%
rgx-314 altitude treatment expansion trial positive diabetic
Transgene Announces Positive Interim Analysis Results of Phase II Trial Evaluating TG4001 + Avelumab vs Avelumab in HPV-Positive Anogenital Cancers
Published: 2022-11-02 (Crawled : 00:00) - biospace.com/
PFE | News A | $26.26 1.0% -0.08% 36M
|
Health Technology
|
| O: -0.5%
H: 0.84%
C: -1.47%
tg4001 trial positive results
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.